Additional file 1: Table S1. of Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

Comparison of patients presenting or not a teicoplanin overdose (teicoplanin plasmatic trough concentration > 25 mg/L) and reaching or not the therapeutic concentration of 15 mg/L during the first 14 days of treatment (DOCX 19 kb)